Pharma Germany is founding North Landes Association for Innovation and Growth

Pharma Germany is founding North Landes Association for Innovation and Growth

Pharma Germany founds the state association North / Northern German pharmaceutical industry bundles forces for innovation and growth

The pharmaceutical industry in northern Germany strengthens its regional representation with the founding of the North State Association. The opening ceremony took place in the clubhouse of the North German Regattaverein in Hamburg. Babette Reiken, managing director at G. Pohl-Boskamp GmbH & Co. KG, was elected head of the new association.

In its function, Reiken commented on the goal of the North State Association: "Our goal is to specifically address and support the concerns of pharmaceutical companies in Schleswig-Holstein, Hamburg, Bremen and Lower Saxony."

REIKET The special features of the northern German pharmaceutical landscape: "Our region is characterized by a unique combination of first -class research institutions and an innovative middle class. In addition, we are also a location of worldwide corporations. We have a dense network of renowned universities and research centers that work closely with the pharmaceutical industry. Pharmaceutical and medical technology companies can be.

Tim Angerer, State Councilor for Health and Work at the Authority of Labor, Health, Social Affairs, Family and Integration of the Free and Hanseatic City of Hamburg, congratulated pharmaceutical Germany to found the state association. He emphasized that the Hamburg Senate views the topic of health as an important future field and that innovations arise when state action and entrepreneurial innovative spirit go hand in hand.

Jörg Wieczorek, CEO of Pharma Germany, explained the regional initiative of the foundation of state associations as the heart of the association work. He added: "A lot has happened since Pharma Germany was founded 4 months ago. With increased work in Brussels, the extraction of additional competence in the area of ​​innovation and the establishment of 5 of the planned 6 state associations shows: something happens to us."

SARAH SAEIDY-NORY, Managing Director of the Association of the Chemical Industry Landesverband Nord (VCI Nord), emphasized the great economic importance of the pharmaceutical industry for the economy in the north and explained that the VCI is at the side of the North State Association as a partner. She emphasized: "The commitment to the competitiveness and performance of the pharmaceutical industry in the north is our common task."

Dorothee Brakmann, Managing Director of Pharma Germany, underlined the strategic importance of the new state association: "The establishment of the North State Association is another step to strengthen our regional presence. Through the local anchoring, we can tackle the specific challenges and opportunities of the region better and develop tailor -made solutions. to represent even more effective. ”

The newly formed board of the North State Association is made up of representatives of leading pharmaceutical companies from the four federal states.

Reiken looked optimistically into the future and explained: “With the establishment of our national association, we start a new phase for our member companies in northern Germany. We look forward to representing the interests of our members as a strong voice and intensifying the constructive exchange with all relevant actors in the region. Our goal is to expand the research and development capacities in northern Germany To secure competitiveness of our region as a pharmaceutical location in the medium and long term. ”

The Landesverband Nord is one of six regional associations that has established Pharma Germany under the roof of the Association of Chemical Industry (VCI). This new structure offers member companies improved opportunities for political influence at the state and federal level, increased visibility in the region and more intensive networking among themselves. The newly founded state association represents the interests of 67 member companies from the pharmaceutical industry.

der Pharma Deutschland e.V. is the largest industry association of the pharmaceutical industry in Germany. He represents the interests of around 400 member companies that employ around 80,000 employees in Germany. The companies organized in Pharma Deutschland e.V. make a significant contribution to securing the supply of drugs in Germany. They provide almost 80 percent of the over -the -counter -free and almost two thirds of the prescription drugs and a large part of the material medical devices for patients. At www.pharmadeutschland.de there is more information about Pharma Germany.